Led by Sandra Ryeom from Stand Up To Cancer team: Stool protein mass spectrometry identifies biomarkers for the early detection of diffuse-type gastric cancer aacrjournals.org/cancerpreventi…

Andy Chan David A. Drew Jeeyun Lee MD Jeremy L. Davis MD, FACS AACR Cancer Prevention Research

Big year for gastroesophageal at #ASCO24 ASCO
ESOPEC plenary
EA2174, ARMANI, and RENAISSANCE in the oral sessions. Karyn Goodman, MD, MS Nataliya Uboha Filippo Pietrantonio ECOG-ACRIN Cancer Research Group Lorenzo Ferri MD PhD Florian Lordick Yelena Y. Janjigian MD Kohei shitara Sara Lonardi Lizzy Smyth Raghav Sundar

GI Series: #UpperGi algorithm, w/ Sam Klempner to reiterate the current landscape:

Full Discussion:
- cancernetwork.com/treatment-algo…
- Oncbrothers.com/upperGIalgo-20…
- Also on the “Oncology Brothers” podcast

#OncTwitter CancerNetwork® #MedTwitter #GISM

Our latest paper in BJS questions the safety of organ-sparing approaches in oesophageal cancer. academic.oup.com/bjs/article/11… 1/12

Out online in parallel with Scott Kopetz #AACR24 presentation. Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer. Nataliya Uboha Rona Yaeger Tanios Bekaii-Saab, MD Cancer Discovery Marcia Cruz-Correa, MD, PhD aacrjournals.org/cancerdiscover…

Was a pleasure to work on the #HPB #OG Scientific Committee for #ASCO24 Thanks to Sam Klempner for your leadership and to all for lively discussions and to ASCO for co-ordinating. Great to see Patrick Forde also.

Reporting association between whole-transcriptome sequencing and IHC. Reasonable concordance regarding HER2 and CLDN18.2 but not 100%. Need further analysis to clarify. OncoAlert #stomachcancer
onlinelibrary.wiley.com/doi/full/10.11…

#ICYMI : Sequential #chemoimmunotherapy in #gastriccancer , by minae an, Arnav Mehta, Byung Hoon Min, You Jeong Heo, Seung Tae Kim, Sam Klempner, Jeeyun Lee MD et al.
bit.ly/48oMuMz
Mass General Cancer Center @Broadinstitute #SamsungMedicalCenter SU2Cscience

Now online in Cancer Discovery: Early Immune Remodeling Steers Clinical Response to Frontline Chemoimmunotherapy in Advanced Gastric Cancer - by minae an, Arnav Mehta, Byung Hoon Min, You Jeong Heo, Seung Tae Kim, Sam Klempner, Jeeyun Lee MD et al. doi.org/10.1158/2159-8…

Happy to share latest international collaboration led by awesome Arnav Mehta minae an and others. Jeeyun Lee MD Cancer Discovery SU2Cscience

Early immune remodeling steers clinical response to frontline chemoimmunotherapy in advanced gastric. aacrjournals.org/cancerdiscover…

MassGeneral Medicine Mass General Cancer Center with lots of representation at Stand Up To Cancer
Erica Warner, ScD David A. Drew Justin Gainor Sam Klempner and missing a few here like Adjoa Anyane-Yeboa, MD MPH Andy Chan and few others non on “x”

What a great start of 2024! Excited, happy and proud to share our latest work published today #openaccess Nature Medicine on the PANDA trial: neoadjuvant atezo+chemo in pts with gastric/GEJ cancers followed by surgery. Some of the key findings below. 1/10 nature.com/articles/s4159…

Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial | Nature Medicine nature.com/articles/s4159…

KEYNOTE-585 is published The Lancet Oncology as presented at #ESMO24 . Pembro+chemo improved pathCR of #gastriccancer but EFS was not statistically significant. MSI-H is distinguished population. Full results of Matterhorn awaited. OncoAlert ESMO - Eur. Oncology ASCO
thelancet.com/journals/lanon…

Online Now: Genomic alterations driving precancerous to cancerous lesions in esophageal cancer development dlvr.it/SzXrS4

Thankful for friends/colleagues/mentors like Jeeyun Lee MD. Leveraging ex-vivo system to interrogate exosomes in gastric cancer. #StomachCancerAwareness month.

Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced GC
science.org/doi/10.1126/sc…

Two fantastic #ASCOplenary sessions around #upperGI cancers tomorrow. Not to miss!

Yelena Y. Janjigian MD Sam Klempner Lizzy Smyth ASCO OncoAlert Tanios Bekaii-Saab, MD

The ASCO Leadership Development Program is excellent. Early-mid career Oncologists who want to accelerate their career growth should absolutely apply. Plus - you get to know current/future ASCO superstars!